24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
Spotlight
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
23andMe
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
teram of use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
10:39
Intel’s decision to keep NEX signals stability for Israel’s 350 networking staff
10:29
Intel VP: “We had 11 or 12 layers of management... now it’s 5 or 6”
21:48
From textile recycling to autonomous vessels: The vision behind the Dream Team startups
20:25
ELNET: German business leaders “are looking with admiration and respect towards the Startup Nation”
More stories
Buzz
Most popular
Daily
Weekly
1
Check Point raises $1.75 billion, potentially eyeing AI expansion
2
Inside the mind of a Nobel physicist: John Martinis on the future of quantum computing
3
Hapag-Lloyd eyes ZIM acquisition, workers push back
4
Cybereason founders' 7AI raises record $130 million Series A in breakneck rise
5
Nice puts Actimize up for sale at a $1.5-2 billion price tag
More news
23andMe
3 stories about 23andMe
23andMe’s downfall: From $3.5 billion IPO to bankruptcy filing
24.03.25
|
CTech and Reuters
A court-supervised sale is now the company’s best hope for the future.
CTech’s top 10 stories of 2024: A year in Israeli high-tech
01.01.25
|
CTech
The most-read articles this year reveal the triumphs, turmoil, and transformations shaping Israel’s tech landscape.
23andMe’s promise of genetic testing has been shattered
06.06.24
|
Viki Auslender
Three years have passed since the IPO of genetic testing company 23andMe and it has faced a nosedive in profits due to public mistrust, a one-time use product, ethical concerns about user data, and security breaches